Keisuke Tonouchi - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Keisuke Tonouchi

Showing results (11-20 of 16) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 16 results.

Cell Reports|July 2, 2025

Antibody durability is influenced by interleukin-2 production by undifferentiated memory T helper cells and extensive B cell clonal expansionMasanori Isogawa, Masahiro Shinoda, Ryutaro Kotaki, et al.

Cell|May 18, 2019

Antibodies to a Conserved Influenza Head Interface Epitope Protect by an IgG Subtype-Dependent MechanismAkiko Watanabe, Kevin R McCarthy, Masayuki Kuraoka, et al.

Nature Communications|July 14, 2023

Structural delineation and computational design of SARS-CoV-2-neutralizing antibodies against Omicron subvariantsSaya Moriyama, Yuki Anraku, Shunta Taminishi, et al.

Science Advances|June 14, 2023

CD62L expression marks SARS-CoV-2 memory B cell subset with preference for neutralizing epitopesTaishi Onodera, Nicolas Sax, Takashi Sato, et al.

Immunity|September 11, 2021

A SARS-CoV-2 antibody broadly neutralizes SARS-related coronaviruses and variants by coordinated recognition of a virus-vulnerable siteTaishi Onodera, Shunsuke Kita, Yu Adachi, et al.

Immunity|July 11, 2021

Temporal maturation of neutralizing antibodies in COVID-19 convalescent individuals improves potency and breadth to circulating SARS-CoV-2 variantsSaya Moriyama, Yu Adachi, Takashi Sato, et al.

Pageof 2

Search research articles

Showing results (11-20 of 16) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 16 results.

Cell Reports|July 2, 2025

Antibody durability is influenced by interleukin-2 production by undifferentiated memory T helper cells and extensive B cell clonal expansionMasanori Isogawa, Masahiro Shinoda, Ryutaro Kotaki, et al.

Cell|May 18, 2019

Antibodies to a Conserved Influenza Head Interface Epitope Protect by an IgG Subtype-Dependent MechanismAkiko Watanabe, Kevin R McCarthy, Masayuki Kuraoka, et al.

Nature Communications|July 14, 2023

Structural delineation and computational design of SARS-CoV-2-neutralizing antibodies against Omicron subvariantsSaya Moriyama, Yuki Anraku, Shunta Taminishi, et al.

Science Advances|June 14, 2023

CD62L expression marks SARS-CoV-2 memory B cell subset with preference for neutralizing epitopesTaishi Onodera, Nicolas Sax, Takashi Sato, et al.

Immunity|September 11, 2021

A SARS-CoV-2 antibody broadly neutralizes SARS-related coronaviruses and variants by coordinated recognition of a virus-vulnerable siteTaishi Onodera, Shunsuke Kita, Yu Adachi, et al.

Immunity|July 11, 2021

Temporal maturation of neutralizing antibodies in COVID-19 convalescent individuals improves potency and breadth to circulating SARS-CoV-2 variantsSaya Moriyama, Yu Adachi, Takashi Sato, et al.

Pageof 2